REOPRO

REOPRO

Manufacturer:

Eli Lilly
Basic Prescribing Info
Contents
abciximab.
CIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AC13 - abciximab ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.
Presentation/Packing
Form
REOPRO inj
Packing/Price
2 mg x 1 mL x 5ml (21,896.8 INR)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in